Vistagen Therapeutics (VTGN) has filed 913 documents with the SEC since September 2007, all on EDGAR under CIK 1411685. In the last 12 months it filed 65, including 1 annual report (10-K), 3 quarterly reports (10-Q), 31 current reports (8-K) and 15 insider filings (Forms 3 and 4). The latest, a 5%+ passive stake (SCHEDULE 13G), was filed on Nov 16, 2026.
https://data.businessquant.com/secfilings?ticker=VTGN&page=1&page_size=50&api_key=YOUR_API_KEY
Pull Vistagen Therapeutics's SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/secfilings?ticker=VTGN&formtype=10-K,10-Q&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/secfilings"
params = {"ticker": "VTGN", "formtype": "10-K,10-Q", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/secfilings?ticker=VTGN&formtype=10-K,10-Q&api_key=YOUR_API_KEY");
const data = await res.json();
Vistagen Therapeutics's Central Index Key (CIK) is 1411685, written 0001411685 in EDGAR's ten-digit form. The SEC files every Vistagen Therapeutics filing under this number.
Its latest annual report, the 10-K for the fiscal year ended Mar 31, 2026, was filed on Jun 15, 2026; its latest quarterly report, the 10-Q for the quarter ended Sep 30, 2026, was filed on Nov 13, 2026.
Vistagen Therapeutics made 65 SEC filings in the last 12 months, most often 31 8-K filings, 12 Form 4 filings and 12 SCHEDULE 13G filings. The most recent, a 5%+ passive stake (SCHEDULE 13G), was filed on Nov 16, 2026.
Yes. The Business Quant SEC Filings API returns Vistagen Therapeutics's filing index (913 filings), with links to every filing and exhibit on EDGAR: /secfilings?ticker=VTGN. Free API keys are available. SEC Filings API docs